Home > Insider Trading > Filing (0001140361-13-035712)

Filing Details

Accession Number:: 0001140361-13-035712
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-11 21:49:35
Reporting Period:: 2013-09-09

Filing Date:: 2013-09-11
Accepted Time:: 2013-09-11 21:49:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070698	Raptor Pharmaceutical Corp	RPTP	Pharmaceutical Preparations (2834)	860883978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1420859	E Thomas Daley	C/O Raptor Pharmaceutical Corp. 5 Hamilton Landing, Suite 160 Novato CA 94949		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-09-09	5,000	$14.24	79,906	No	4	S	Direct
Common Stock	Disposition	2013-09-09	5,000	$14.24	74,906	No	4	S	Direct
Common Stock	Disposition	2013-09-09	5,000	$14.24	69,906	No	4	S	Direct
Common Stock	Acquisiton	2013-09-09	10,000	$2.23	79,906	No	4	M	Direct
Common Stock	Disposition	2013-09-09	10,000	$14.33	69,906	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock options (right to buy)	Disposition	2013-09-09	10,000	$0.00	10,000	$2.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,969	2008-03-10	2017-09-10	No	4	M	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
Options were issued pursuant to the Issuers 2006 Equity Incentive Plan. Options vest 6/48ths on March 10, 2008 and 1/48th per month thereafter.
This transaction was executed in multiple trades at prices ranging from $14.07 to $14.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $14.10 to $14.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $14.10 to $14.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $14.22 to $14.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares listed as owned in column 9 represents the total shares that remain outstanding for this option grant dated 9/10/2007.
Fully vested and exercisable.